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Cytokines are key regulatory mediators involved in the host response to immunological
challenges, but also play a critical role in the communication between the immune and
the central nervous system. For this, their expression in both systems is under a tight
regulatory control. However, pathological conditions may lead to an overproduction of
pro-inflammatory cytokines that may have a detrimental impact on central nervous system.
In particular, they may damage neuronal structure and function leading to deficits of
neuroplasticity, the ability of nervous system to perceive, respond and adapt to external
or internal stimuli. In search of the mechanisms by which pro-inflammatory cytokines may
affect this crucial brain capability, we will discuss one of the most interesting hypotheses:
the involvement of the neurotrophin brain-derived neurotrophic factor (BDNF), which
represents one of the major mediators of neuroplasticity.
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NEUROPLASTICITY AND BRAIN-DERIVED NEUROTROPHIC
FACTOR
For many years the medical field held the belief that the brain
did not make major changes after a certain point in time. It was
fixed or set on a specific path. Today, in contrast, we know that the
brain is actually capable of changing and developing throughout
a lifetime. It is plastic or malleable, and the term neuroplasticity is
used to describe this tendency for the brain to keep developing,
changing, and potentially healing itself.
Specifically, neuroplasticity or neuronal plasticity refers to the
ability of the nervous system to respond and adapt to environ-
mental challenges and encompasses a series of functional and
structural mechanisms that may lead to neuronal remodeling,
formation of novel synapses and birth of new neurons. Neu-
ronal plasticity is intimately linked to cellular responsiveness and
may therefore be considered an index of the neuronal capability
to adapt its function to a different demand. Failure of such
mechanisms might enhance the susceptibility to environmental
challenges, such as stress, and ultimately lead to psychopathology.
Among the genes responsive to neuronal activity, neurotrophic
factors (NTFs), and in particular the neurotrophin family, play
an important role. In fact, besides their classical role in sup-
porting neuronal survival, NTFs finely modulate all the cru-
cial steps of network construction, from neuronal migration
to experience-dependent refinement of local connections (Poo,
2001). These functions were first reported based on the observa-
tion that, during the development of the nervous system, neu-
ron survival depends on the limited amount of specific NTFs
secreted by target cells (Huang and Reichardt, 2001). However,
it is now well established that NTFs are important mediators
of neuronal plasticity also in adulthood where they modu-
late axonal and dendritic growth and remodeling, membrane
receptor trafficking, neurotransmitter release, synapse forma-
tion and function (Lu et al., 2005). The neurotrophin brain-
derived neurotrophic factor (BDNF) has emerged as crucial
mediator of neuronal plasticity, since it is abundant in brain
regions particularly relevant for plasticity, but also because it
shows a remarkable activity-dependent regulation of expres-
sion and secretion (Bramham and Messaoudi, 2005), suggesting
that it might indeed bridge experience with enduring change
in neuronal function. BDNF has a complex genomic struc-
ture, which results into a sophisticated organization in terms
of transcriptional, translational and post-translational regulatory
mechanisms (Aid et al., 2007). In particular, the rat BDNF
gene—that is similar to the human gene—can generate nine
distinct transcripts through the alternative splicing of 5’
un-translated exons to a common 3’ exon (IX), which encodes the
BDNF protein (Aid et al., 2007). These transcripts have different
distribution and/or translation efficacy and, more importantly,
may sub-serve different functions. For example, transcripts that
are primarily localized or targeted to dendrites may sustain local
neurotrophin production, thus providing an effective mechanism
to regulate synaptic structure and function (An et al., 2008; Wu
et al., 2011). Since the transcription of the different isoforms
is regulated by specific signaling pathways (Pruunsild et al.,
2011), their investigation may provide useful information on the
up-stream mechanisms contributing to the changes of BDNF gene
expression.
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The mechanisms that lie downstream from NTFs and
contribute to the maintenance of neuroplasticity are different i.e.,
adult neurogenesis and neuronal remodeling, but on the purpose
of this mini-review we will focus only on adult neurogenesis,
the process by which neurons are generated. Neurogenesis occurs
under precise spatial and temporal control, but it can be modu-
lated by both internal and external stimuli. Among these, several
sources of data indicate the positive impact of BDNF on adult
neurogenesis (Lee et al., 2002; Sairanen et al., 2005; Scharfman
et al., 2005; Gass and Riva, 2007; Bergami et al., 2008; Chan
et al., 2008; Li et al., 2008; Waterhouse et al., 2012), however
in this review we will focus our attention on the effects of pro-
inflammatory cytokines.
NEUROGENESIS AND INFLAMMATORY STATE
Neurogenesis has been defined as the process in which new-
born neurons are generated from progenitors to functionally
integrate in the neuronal network (Ming and Song, 2005; Balu
and Lucki, 2009; Aimone et al., 2014). Actually, active neuro-
genesis take place, in the healthy central nervous system, only
in two specific regions: neurons are continuously generated in
the sub-ventricular zone (SVZ) and migrate into the olfactory
bulb to become interneurons and, in parallel, neurogenesis occurs
also in the sub-granular zone (SGZ) of the dentate gyrus of
the hippocampus, where new granule neurons are continually
generated. Depending on different stimuli, neural stem cells,
located in so-called stem cell niches, could divide symmetrically,
leading to the generation of two identical cells to maintain
the pool of undifferentiated progenitors or, on the other hand,
they can divide asymmetrically in order to generate an identical
daughter cell and a second cell that starts to differentiate. The
de novo formation and integration of new neurons into the
existing circuitry is one of the various plastic changes that allow
the adult brain to adapt to exogenous stimuli (Amrein et al.,
2011). In particular, adult neurogenesis within the hippocampus
could contribute to enhanced neural plasticity, a process that is
fundamental for specific brain functions such as spatial learning,
pattern discrimination, contextual memory and mood regulation
(Clelland et al., 2009; Sahay et al., 2011; Denny et al., 2014).
The important role of hippocampal neurogenesis is underlined by
the fact that this system is altered after various types of negative
stimuli such as stress, one of the major risk factors for psy-
chiatric diseases. Specifically, repeated restraint and inescapable
foot shock, two examples of physical stressors, inhibit one or
more steps of adult neurogenesis in the dentate gyrus (Mal-
berg and Duman, 2003; Pham et al., 2003); the social defeat
paradigm leads to an inhibitory effect on cell proliferation and
survival of newborn granule neurons in rodents (Czéh et al., 2002;
Jun et al., 2012); and social isolation, which is associated with
decreased neurogenesis and behavioral alterations in rodents,
has been recently proven to be deleterious also for hippocampal
neurogenesis and behavior in non human primates (Cinini et al.,
2014).
As previously mentioned, neurogenesis is conditioned by
a very complex microenvironment constituted by the vascu-
lar net, different growth and NTFs, changes in electrical and
chemical environment and support by glial cells (Kohman and
Rhodes, 2013). In this scenario, neuroinflammation is emerg-
ing as one of the main actors. In fact the immune system,
through cells within the brain (e.g., microglia) and the detri-
mental or the beneficial action of signaling molecules (pro-
inflammatory or anti-inflammatory cytokines) could participate
in the response to different exogenous and endogenous stimuli.
The negative effects of neuroinflammation on neurogenesis could
lead to impaired survival and proliferation of new neurons.
For example, intracortical or intraperitoneal administration of
lipopolysaccaride (LPS) from E. coli, an agent able to induce a
strong immune response, decreases new neurons survival and
the differentiation of new cells into neurons (Ekdahl et al., 2003;
Monje et al., 2003). The consequences of inflammation on neu-
rogenesis could have also functional implications for cognition.
In fact, the impact of neuroinflammation could affect also the
correct integration of newborn neurons into pre-existing circuits,
through changes in cellular morphology and in electrophysiolog-
ical properties (Jakubs et al., 2008) and reduction in recruitment
into hippocampal networks encoding spatial information (Belarbi
et al., 2012).
THE IMPACT OF PRO-INFLAMMATORY CYTOKINES ON
NEUROGENESIS
Neuroinflammation has an important role in the pathophysiol-
ogy of different acute or chronic CNS disorders such as cere-
bral ischemia, multiple sclerosis, Alzheimer’s disease, Parkinson’s
disease and major depression (Wang and Jin, 2014). These dis-
eases are characterized by the modulation of different mediators
of inflammation and among them pro-inflammatory cytokines
seem to play a key role. It is important to note that the same
cytokines that in a physiological state are involved in the mainte-
nance of neuronal integrity, may instead have detrimental effects
under pathological conditions. Accordingly, the impact of the
pro-inflammatory cytokines on neurogenesis depends on their
concentration, on the specific cells activated (astrocytes and
microglia) and on the presence of other factors secreted in the
neurogenic niche (Eyre and Baune, 2012). The increase of pro-
inflammatory cytokines is not only due to a direct inflamma-
tory stimulus (infection or trauma), but it could be caused by
environmental stimuli such as stress (García-Bueno et al., 2008).
The main consequence of a dysregulation of cytokine levels
within the brain is the production of inflammatory, oxidative
and nitrosative molecules that could affect neurogenesis and
the neural homeostasis (Kubera et al., 2011; Stepanichev et al.,
2014).
The most common pro-inflammatory cytokines are IL-1β,
IL-6, TNF-α and IFN-γ and here we will present some examples
of the involvement of these molecules in the modulation of
neurogenesis.
The main actions of IL-1β are the stimulation of immune
cells to produce pro-inflammatory cytokines, the activation of
microglia, and the regulation of growth factors activity (Audet
and Anisman, 2013). Recently, IL-1β has been proven to influence
hippocampal cytogenesis and neurogenesis in different ways: by
direct interaction to its receptor (IL-1R1) and the consequent
activation of the nuclear factor-kappa B (NFkB; Koo and Duman,
2008) or through the promotion of glucocorticoids secretion
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after the exposure to environmental stressors (Goshen et al.,
2008). Moreover this cytokine has been proposed as the central
mediator of antineurogenic effect of stress (Ben Menachem-
Zidon et al., 2008). In fact the blockade of IL-1β signaling, using
knockout mice for its receptor or administrating a IL-1R1 antag-
onist (IL-1Ra), prevents the decrease in neurogenesis observed
after acute stressors such as footshock and immobilization in
rats (Koo and Duman, 2008). Another relevant cytokine is IL-
6 that is involved in a multitude of neuroprotective functions.
In physiological conditions IL-6 is able to activate pathways
related to neural plasticity, neurogenesis, Long Term Potentiation,
and memory (Eyre and Baune, 2012). On the other hand, this
cytokine is also responsible of mediating synthesis of acute phase
proteins, growth and differentiation of immune cells and regu-
lation of pro-inflammatory factors (Audet and Anisman, 2013).
Monje et al. demonstrated that the incubation of hippocampal
progenitor cells with recombinant IL-6 decreases neurogenesis
by half and reduces neuronal differentiation in favor of astro-
cytogenesis (Monje et al., 2003; Taga and Fukuda, 2005), an
effect mediated by the activation of the JAK/STAT3 pathway
via gp130 (Namihira and Nakashima, 2013). Tumor necrosis
factor—alpha (TNF-α) is a potent inductor of inflammation
and has been linked to decreased neural stem cell proliferation,
decreased neurogenesis, neurodegenerative processes, apoptosis
and excitotoxicity (Dantzer et al., 2008; Belarbi et al., 2012),
but also to the modulation of synaptic strength and synaptic
preservation through the increase of the α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors (Khairova
et al., 2009). The negative action of TNF-α on neurogenesis is
mediated by the activation of its receptor TNF-R1, conversely
the interaction with TNF-R2 increases proliferation and survival
of newborn neurons, as demonstrated by using transgenic ani-
mals with deletion of TNF-R1 or TNF-R2 (Iosif et al., 2006). A
similar result on the beneficial role of TNF-R2 activation after
irradiation injury has been recently reported (Chen and Palmer,
2013). Moreover, the up-regulation of TNF-α observed in the
hippocampus of adult rats pre-exposed to maternal deprivation
has been associated with impaired memory consolidation (Pin-
heiro et al., 2014). IFN-γ is a pro-inflammatory cytokine with in
vitro anti-neurogenic effect able to reduce the number of neural
stem cells. The negative action of IFN-γ on neurogenesis may
be exerted by the activation of the caspase 3/7, the upregula-
tion of sonic hedgehog (SHH) pathway and promotion of an
abnormal marker profile of neural stem cells, expressing both
GFAP and βIII tubulin (Walter et al., 2011). Nevertheless, IFN-
γ may also exerts positive action on neurogenesis. For example,
it enhances neurogenesis in dentate gyrus of adult mice and
ameliorates spatial learning and memory performance (Baron
et al., 2008). These observations suggest that IFN-γ has different
effects depending on tissues involved and on the neurogenic
process involved.
Taken together, all these studies indicate that a dysregulation
of pro-inflammatory cytokines may have a detrimental effect on
neurogenesis and point out the importance of neuroinflamma-
tion in the microenvironment around neural stem cell develop-
ment. On this context, the identification and characterization
of the mechanisms by which pro-inflammatory cytokines affect
neurogenesis are crucial to develop new strategies to maintain the
proper function of stem cell niches within the brain.
THE IMPACT OF PRO-INFLAMMATORY CYTOKINES ON BDNF
Given the role of BDNF as an important mediator of neuroplas-
ticity and on the basis of its positive contribution on neuroge-
nesis in contrast to the detrimental effect of pro-inflammatory
cytokines, we may hypothesize that one of the mechanisms by
which inflammation may affect brain function could involve
BDNF modulation.
Several in vivo studies demonstrated that inflammation clearly
affects the expression of BDNF within the brain. In particular, it
has been reported that the administration of pro-inflammatory
cytokines or of the cytokine-inducer lipopolysaccharide, (LPS;
Raetz and Whitfield, 2002) causes a significant reduction of
BDNF gene expression. For example, the mRNA levels of BDNF
were significantly decreased in the rat hippocampus 4 h after
intraperitoneal injection of IL-1β or LPS (Lapchak et al., 1993)
and a similar reduction was also observed in several cortical
regions and at protein level (Guan and Fang, 2006; Schnydrig
et al., 2007). Interestingly, the effect of the systemic inflammatory
challenge was not restricted to BDNF: other neurotrophins such
as nerve growth factor (NGF) and neurotrophin-3 (NT-3) were
similarly reduced although with different magnitude (Guan and
Fang, 2006).
Recently, it has also been evaluated the effect of peripheral
immune challenge on the different BDNF transcripts, finding
that the expression of exons I, II, and IV in the dentate gyrus
was reduced in the CA1 and in the dentate gyrus of rats acutely
treated with E. coli (Chapman et al., 2012), indicating that
inflammation may affect specific isoforms of the neurotrophin.
Nevertheless, there is a critical lack of information about the
effects of inflammation on the expression of specific BDNF tran-
scripts and further studies are demanded in order to clarify the
mechanisms involved in the modulation of the neurotrophin by
the immune/inflammatory system.
The negative impact of inflammation on BDNF has impor-
tant implications for a number of pathological conditions. For
example, it is known that pro-inflammatory cytokines com-
promise hippocampus-dependent memory (Pugh et al., 1998),
spatial memory (Arai et al., 2001) and increase apoptosis in
the brain (Nolan et al., 2003), features that are involved in
many aging-associated pathologies and neurodegenerative dis-
eases. In addition, it is well-know that the activation of the
immune/inflammatory system may contribute to the develop-
ment of different psychiatric diseases such as schizophrenia and
major depression (Dantzer et al., 2008; Miller et al., 2009; Leonard
and Maes, 2012; Zunszain et al., 2013). Regarding depression,
there are three main supportive evidences: first, depressed subjects
exhibit increased levels of inflammatory markers both in the
periphery and in brain (Howren et al., 2009; Dowlati et al., 2010);
second: several pathologies associated with moderate inflamma-
tory grade present high depression comorbidity (Benton et al.,
2007); third: a high percentage of patients with cancer or hep-
atitis C treated with interferon-alpha develop major depression
(Valentine and Meyers, 2005; Udina et al., 2012). In addition,
it has to be noted that animals exposed to immune challenges
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FIGURE 1 | Immune/inflammatory alterations and changes in BDNF expression and function are characteristic of the same pathologies, for example
major depression, suggesting a cross-talk between the two systems.
display depressive-like behaviors (Yirmiya, 1996; Frenois et al.,
2007) that can be normalized, or at least limited, by antidepressant
treatment (Yirmiya et al., 2001). In contrast, mice that lack IL-6
are stress resistant and have a reduced disposition for depressive-
like behaviors (Chourbaji et al., 2006). The mechanism under-
lying the anti-inflammatory properties of antidepressant is still
unknown and is beyond the aim of our mini-review. However,
the results of several in vitro and in vivo studies indicate that
these drugs are able to modulate cytokine functioning through
their effects on intracellular cyclic adenosyl monophosphate,
serotonin metabolism, the hypothalamo-pituitary-adrenocortical
axis (Janssen et al., 2010; Walker, 2013; Leonard, 2014).
It is important to consider that the immune/inflammatory
alterations previously described are actually in parallel with
changes on BDNF expression and function (Figure 1). Indeed,
BDNF has a well recognized role in the etiology as well as in the
treatment response of patients affected by different psychiatric
disorders including major depression (Pezet and Malcangio, 2004;
Duman and Monteggia, 2006). For example, decreased expression
of the neurotrophin has been found in the hippocampus and pre-
frontal cortex of postmortem brains from depressed and suicide
victims (Dwivedi et al., 2003). Moreover, BDNF mRNA levels are
reduced in the brain of genetic animal models of depression (Rid-
der et al., 2005; Calabrese et al., 2010; Molteni et al., 2010a,c) as
well as in animal models based on the environmental component
of the disease (Duman and Monteggia, 2006; Tsankova et al., 2006;
Chourbaji et al., 2012).
All these findings support the possibility that inflammation
contributes to the development of depression by compromising
neuroplasticity via reduction of BDNF. In agreement with this
line of thinking, it has been recently reported that intranigral
LPS infusion induced an anxious and depressive phenotype in the
rat that was associated with decreased hippocampal expression of
BDNF (Hritcu and Gorgan, 2014).
In order to have a unequivocal proof for causality,
inflammation-dependent decrease of BDNF should be
normalized or at least attenuated by antidepressant treatment,
as occurs in experimental models where BDNF expression is
up-regulated in response to prolonged treatment with different
antidepressant drugs (Schmidt and Duman, 2007; Calabrese
et al., 2010; Molteni et al., 2010b; Park et al., 2011).
FIGURE 2 | Detrimental effect of pro-inflammatory cytokines on
neuroplasticity may be mediated by BDNF.
Although there are only few data on this issue, it has been
demonstrated that the incubation of rat neural stem cells with
the antidepressant imipramine inhibits the production of pro-
inflammatory cytokines, whereas stimulates the expression of
BDNF (Peng et al., 2008), nevertheless, further studies are
demanded to clarify this issue in order to provide unequivocal
proof for causality.
CONCLUDING REMARKS
In conclusion, we attempted to provide evidence on the possibility
that one of the mechanisms underlying the negative impact of
pro-inflammatory cytokines on neuroplasticity is the reduction
of BDNF expression and function (Figure 2).
Although several data support this hypothesis, further studies
are demanded to better clarify how it occurs. A number of result
points out a key role for the pro-inflammatory cytokine IL-1β as
it has been shown that the inhibitory effect of stress paradigms on
cerebral BDNF expression may be attenuated by intracerebroven-
tricular injection of IL-1 receptor antagonist (Barrientos et al.,
2003). However, how this -or others- pro-inflammatory cytokine
affects the neurotrophin is still not well understood. Since in
vitro and in vivo studies indicate that glucocorticoids decrease
the neurotrophin (Hansson et al., 2003; Gubba et al., 2004;
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Hansson and Fuxe, 2008), one possibility is the involvement of the
Hypotalamus-Pituitary-Axis (HPA), which is strongly stimulated
by pro-inflammatory cytokines (Rivest, 2010). However, we have
to be aware that pro-inflammatory cytokines act on a plethora
of different targets, for example the neurotransmitters glutamate
(Viviani et al., 2007; Di Filippo et al., 2013) and GABA (Galic
et al., 2012), both able to modulate BDNF. In this context, it
is feasible that the effect of the immune/inflammatory system
on BDNF results from the integration of multiple mechanisms.
A better knowledge of these events may be useful to develop new
therapeutic strategies aimed to normalize, or at least ameliorate,
the pathological consequences of the negative impact of inflam-
mation on brain structure and function.
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